TotalMarketCap

InMed Pharmaceuticals

INMNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.145 M

$13.01 -25.69%

Close of 6 Nov 2026

As of 6 Nov 2026, InMed Pharmaceuticals (INM) has a market capitalization of $7.14M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.94M

#3264 by revenue

Earnings

-$1.70M

Loss-making

Shares outstanding

5,493,735

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #431Vistagen TherapeuticsVTGN$7.37M
  2. #432SoligenixSNGX$7.25M
  3. #433InMed PharmaceuticalsINM$7.14M
  4. #434Aprea TherapeuticsAPRE$7.03M
  5. #435Universe PharmaceuticalsUPC$6.98M

What if InMed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$51,398,270

Per share 3,952,193× higher

Bitcoin $1.53T

$2,781,071

Per share 213,846× higher

Apple $5.02T

$9,129,996

Per share 702,037× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for InMed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.